Abstract
New derivatives of E-64 (compound CA-030 and CA-074) were tested in vitro and in vivo for selective inhibition of cathepsin B. They exhibited 10000-30000 times greater inhibitory effects on purified rat cathepsin B than on cathepsin H and L; their initial K1 values for cathepsin B were about 2-5 nM, like that of E-64-c, whereas their initial K1 values for cathepsins H and L were about 40-200 μM. In in vivo conditions, such us intraperitoneal injection of compound CA-030 or CA-074 into rats, compound CA-074 is an especially potent selective inhibitor of cathepsin B, whereas compound CA-030 does not show selectivity for cathepsin B, although both compounds CA-030 and CA-074 show complete selectivity for cathepsin B in vitro. © 1991.
Author supplied keywords
Cite
CITATION STYLE
Towatari, T., Nikawa, T., Murata, M., Yokoo, C., Tamai, M., Hanada, K., & Katunuma, N. (1991). Novel epoxysuccinyl peptides A selective inhibitor of cathepsin B, in vivo. FEBS Letters, 280(2), 311–315. https://doi.org/10.1016/0014-5793(91)80319-X
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.